Mammalian Target Rapamycin Inhibition as a Therapeutic Target for Prevention of Proliferative Vitreoretinopathy.

چکیده

The use of systemic mammalian target of rapamycin (mTOR) inhibitor (MTI) therapy may confer benefits against the development of proliferative vitreoretinopathy (PVR). To examine the use of systemic MTI therapy for the prevention of PVR among patients who underwent initial retinal detachment (RD)…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط